CORT
Corcept Therapeutics Incorporated
Stock
$116.23+2.20 (+1.93%)Close Oct 2, 2026
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $831M | +16.6% |
| Gross profit | $817M | +16.5% |
| Operating income | $6.4M | −19.0% |
| Net income | $55M | −1.2% |
| EPS | $0.42 | −0.7% |
| Free cash flow | $107M | −1.2% |